Praxis Precision Medicines Inc. (PRAX) PT Raised to $251 at TD Cowen as Ph3 ET Ulixa Studies Meet Primary
Tweet Send to a Friend
TD Cowen analyst Ritu Baral raised the price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX) to $251.00 (from $61.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
